GRP and prostate carcinoma: Moreover, in the prostate carcinoma PC-3 cell model, the action of the gastrin releasing peptide (GRP) analog, bombesin (BN), on the activation of focal adhesion kinase (FAK) and its invasiveness suggests that this kinase might favor metastasis (Lacoste, Aprikian & Chevalier, 2005).